Evidence map›Paper›PMID 42360038›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Engendering trustworthiness in the community: Strategies for researchers.

Shenikqua Bouges, Esra Alagoz, Diana Gutierrez-Meza, Debra Noell, Fauzia Hollnagel, Alayna Oby, Susan Flowers-Benton, Barbara Fischer, Diane C Gooding, Ruben L Anthony and 11 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Shenikqua BougesDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.ORCID 0000-0002-4452-0548
Esra AlagozDepartment of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Diana Gutierrez-MezaDepartment of Surgery, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Debra NoellDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Fauzia HollnagelDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Alayna ObyDepartment of Psychology, William S. Middleton Memorial Hospital, Madison, WI, USA.
Susan Flowers-BentonDepartment of Rehabilitation, Disability Studies, and Counseling, Southern University and A&M College, Baton Rouge, LA, USA.
Barbara FischerMadison VA GRECC, William S. Middleton Memorial Hospital, Madison, WI, USA.
Diane C GoodingWisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Ruben L AnthonyUrban League of Greater Madison, Madison, WI, USA.
Fabu P CarterDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Gilda E EnnisDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Carol Van HulleDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Megan ZuelsdorffWisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Nickolas H LambrouDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Taryn T JamesDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Emre UmucuDepartment of Public Health Sciences, The University of Texas at El Paso, El Paso, TX, USA.
Cynthia M CarlssonDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Sanjay AsthanaDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Carey E GleasonDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Susan Racine PassmoreSchool of Nursing, University of Wisconsin-Madison, Madison, WI, USA.

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
NCATS NIH HHS UL1 TR002373
6 · The paper itself

Abstract

BackgroundDespite significant advances in Alzheimer's disease treatment, underrepresentation of ethnoracialized groups in clinical trials limit the generalizability of study findings. Though mistrust in health care research is a known barrier to clinical trial participation, methods are needed to quantitate this multidimensional subjective term. This study investigated how Black participants view trustworthiness.ObjectiveTo provide an overview of participants' views of a trustworthy study design and investigator.MethodsThis qualitative study utilized focus group discussions with Black participants 45 years and older. Transcripts were coded by three researchers by means of content analysis. After central categories were identified using concept mapping, we constructed a conceptual model of trust to reflect participants' views of trustworthiness.ResultsParticipants self-identified as Black, were a mean age of 62, and predominantly female (80%). Focus group analysis revealed that a trustworthy study design and its impact as well as a trustworthy investigator were central categories of trustworthiness. Comprehensive study outlines, detailed information on the disease being studied, and sharing of study results improved participants' willingness to be involved in studies. Participants also value researchers who are scientifically and culturally competent, knowledgeable, attentive and who engage in education and sharing comprehensive resources on diseases impacting vulnerable populations.ConclusionsThese findings suggest that trustworthy features of the study design and researcher characteristics can provide a foothold to build trust with a population whose mistrust of research is well-documented. Further research on trustworthiness is necessary to develop tools to create a framework for building a trustworthy research environment.

Indexed as

Black or African AmericanResearch PersonnelTrustAgedAlzheimer DiseaseFemaleFocus GroupsHumansMaleMiddle AgedQualitative ResearchResearch DesignAlzheimer's diseaseattitudefocus groupstrust

Identifiers

PMID42360038
PMCPMC13392159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.